+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Stroke Management Market (2018 - 2024)

  • ID: 4721702
  • Report
  • Region: Europe
  • 98 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • MORE
The Europe Stroke Management Market is expected to witness market growth of 6.7% CAGR during the forecast period (2018 - 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advanced devices and drugs is expected to limit the market growth.

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Stroke Management Market, by Type
1.4.2 Europe Stroke Management Market, by Application
1.4.3 Europe Stroke Management Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Stroke Management Market by Type
3.1.1 Europe Diagnostics Stroke Management Market by Country
3.1.1.1 Europe Stroke Management Market by Diagnostics Type
3.1.1.1.1 Europe Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2 Europe Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3 Europe Stroke Management Echocardiography Market by Country
3.1.1.1.4 Europe Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5 Europe Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6 Europe Stroke Management Electrocardiography Market by Country
3.1.1.1.7 Europe Other Diagnostics Type Stroke Management Market by Country
3.1.2 Europe Therapeutics Stroke Management Market by Country
3.1.2.1 Europe Stroke Management Market by Therapeutics Type
3.1.2.1.1 Europe Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2 Europe Anticoagulant Stroke Management Market by Country
3.1.2.1.3 Europe Antiplatelet Stroke Management Market by Country
3.1.2.1.4 Europe Other Therapeutics Type Stroke Management Market by Country

Chapter 4. Europe Stroke Management Market by Application
4.1.1 Europe Ischemic Stroke Management Market by Country
4.1.2 Europe Haemorrhagic Stroke Management Market by Country

Chapter 5. Europe Stroke Management Market by Country
5.1 Germany Stroke Management Market
5.1.1 Germany Stroke Management Market by Type
5.1.1.1 Germany Stroke Management Market by Diagnostics Type
5.1.1.2 Germany Stroke Management Market by Therapeutics Type
5.1.2 Germany Stroke Management Market by Application
5.2 UK Stroke Management Market
5.2.1 UK Stroke Management Market by Type
5.2.1.1 UK Stroke Management Market by Diagnostics Type
5.2.1.2 UK Stroke Management Market by Therapeutics Type
5.2.2 UK Stroke Management Market by Application
5.3 France Stroke Management Market
5.3.1 France Stroke Management Market by Type
5.3.1.1 France Stroke Management Market by Diagnostics Type
5.3.1.2 France Stroke Management Market by Therapeutics Type
5.3.2 France Stroke Management Market by Application
5.4 Russia Stroke Management Market
5.4.1 Russia Stroke Management Market by Type
5.4.1.1 Russia Stroke Management Market by Diagnostics Type
5.4.1.2 Russia Stroke Management Market by Therapeutics Type
5.4.2 Russia Stroke Management Market by Application
5.5 Spain Stroke Management Market
5.5.1 Spain Stroke Management Market by Type
5.5.1.1 Spain Stroke Management Market by Diagnostics Type
5.5.1.2 Spain Stroke Management Market by Therapeutics Type
5.5.2 Spain Stroke Management Market by Application
5.6 Italy Stroke Management Market
5.6.1 Italy Stroke Management Market by Type
5.6.1.1 Italy Stroke Management Market by Diagnostics Type
5.6.1.2 Italy Stroke Management Market by Therapeutics Type
5.6.2 Italy Stroke Management Market by Application
5.7 Rest of Europe Stroke Management Market
5.7.1 Rest of Europe Stroke Management Market by Type
5.7.1.1 Rest of Europe Stroke Management Market by Diagnostics Type
5.7.1.2 Rest of Europe Stroke Management Market by Therapeutics Type
5.7.2 Rest of Europe Stroke Management Market by Application

Chapter 6. Company Profiles
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.3 Cardinal Health
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.4 Medtronic Plc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 General Electric (GE) (GE Healthcare)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Siemens Healthineers
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental Analysis
6.6.4 Research & Development Expense
6.7 Bristol-Myers Squibb
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Merck & Company Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expense
6.9 Glaxosmithkline Plc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ABBOTT Laboratories
  • B. Braun Melsungen Ag
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Medtronic Plc
  • Siemens Aktiengesellschaft
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4721702
Adroll
adroll